Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Respiratory · Lancet · 2026-11-14
RCTn = 558
Domínguez-Rodríguez et al. Empirical tuberculosis treatment in infants living with HIV hospitalised with severe pneumonia in Africa (EMPIRICAL): a multicentre, randomised, open-label, 2 × 2 factorial, controlled superiority trialRespiratory · BMJ · 2026-11-04
RCTn = 400
Han et al. Perioperative respiratory adverse events in children undergoing adenotonsillectomy with laryngeal mask airway versus endotracheal tube ventilation: multicentre, randomised controlled trialRespiratory · Lancet · 2026-10-31
RCTn = 424
Curley et al. Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trialRespiratory · Lancet Respir Med · 2026-09-18
Meta-analysisn = 84,128
Linde et al. Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysisRespiratory · Lancet Respir Med · 2026-09-15
Meta-analysisn = 8,130
Roy et al. Accuracy of type 2 inflammatory biomarkers to diagnose asthma in adults and children: a meta-analysis of 30 studies with prospective validation in an adult primary care cohortRespiratory · N Engl J Med · 2026-09-08
RCTn = 1,750
Sciurba et al. Tozorakimab to Prevent COPD ExacerbationsRespiratory · Lancet · 2026-09-07
RCTn = 822
Morgan et al. Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trialRespiratory · Lancet Respir Med · 2026-08-25
RCTn = 166
Gerber et al. Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trialRespiratory · Lancet Respir Med · 2026-08-20
Meta-analysisn = 7,161
Couillard et al. Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies